Support and Resistance Basics

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top 10 Correlated Stocks

TDOC


In the News

04:20 13 Aug 2022 TDOC

This beaten down Cathie Wood stock is a ‘buy': DA Davidson

Shares of Teladoc Health Inc (NYSE: TDOC) are in focus on Friday after a DA Davidson analyst said the beaten down telemedicine company is a “buy” at current levels.

11:00 13 Aug 2022 TDOC

3 People That Still Believe in Teladoc

Teladoc stock has fallen 88% since peaking last year. There are still investors that feel the time is right to buy or add to a position.

07:03 13 Aug 2022 TDOC

Why Teladoc Crawled Only Marginally Higher on Thursday

An analyst's positive new take on the company is mitigated by concerns about its recent performance.

04:33 13 Aug 2022 TDOC

Revisiting the Pandemic Winners: Time to Buy?

Those who flocked to the stay-at-home type of stocks during the pandemic were rewarded handsomely with considerable gains. In 2022, the story has been vividly different.

02:46 13 Aug 2022 TDOC

Cathie Wood Is Buying Teladoc (TDOC) Stock Up in a Frenzy

Shares of telehealth company Teladoc (NYSE: TDOC ) are in the spotlight, as Cathie Wood's Ark Invest has purchased shares of the company every day this week. From Aug. 8 to Aug. 10, Ark purchased 344,629 shares of TDOC stock.

12:24 13 Aug 2022 TDOC

Cathie Wood Is Doubling Down on Biotech Stocks DNA, NVTA, TDOC

It appears Cathie Wood is as long on biotech stocks as ever. The Ark Invest founder and manager has been buying up popular biotech companies like Ginkgo Bioworks (NYSE: DNA ), Invitae (NYSE: NVTA ) and Teladoc (NYSE: TDOC ) en masse this summer.

05:06 13 Aug 2022 TDOC

3 Supercharged Growth Stocks Down 88% to 93% That Billionaires Can't Stop Buying

Not even a bear market decline can faze billionaire money managers who are intent on owning innovative companies and future industry leaders.

06:10 13 Aug 2022 TDOC

Cathie Wood's Ark Invest Adds $4.5M In Teladoc Stock

Cathie Wood-led Ark Investment Management bought 129,800 shares of healthcare company Teladoc Health Inc (NYSE: TDOC), valued at over $4.5 million, based on Tuesday's closing price, via four of its exchange-traded funds (ETFs).

09:53 13 Aug 2022 TDOC

Why Teladoc Might Never Be a Warren Buffett Stock

The stock just isn't a fit for the billionaire investor's portfolio, and it's not for the reasons you might think.

10:45 13 Aug 2022 TDOC

Is There any Hope for Teladoc Stock in 2023?

Its recent performance leaves a lot to be desired.

Financial details

Company Rating
Neutral
Market Cap
6.06B
Income
-9.87B
Revenue
2.23B
Book val./share
37.7
Cash/share
5.48
Dividend
-
Dividend %
-
Employees
4.34K
Optionable
No
Shortable
Yes
Earnings
25 Oct 2022
P/E
-0.66
Forward P/E
-1.11
PEG
-0.01
P/S
2.91
P/B
1.07
P/C
7.36
P/FCF
60.91
Quick Ratio
2.93
Current Ratio
3.38
Debt / Equity
0.26
LT Debt / Equity
0.26
-
-
EPS (TTM)
-61.4
EPS next Y
-36.42
EPS next Q
-0.85
EPS this Y
-11.61%
EPS next Y
-40.68%
EPS next 5Y
-40.68%
EPS last 5Y
19.67%
Revenue last 5Y
54.18%
Revenue Q/Q
4.78%
EPS Q/Q
-53.78%
-
-
-
-
SMA20
-5.63%
SMA50
13.46%
SMA100
-38.1%
Inst Own
87.42%
Inst Trans
-0.72%
ROA
-122%
ROE
-84%
ROC
-1.28%
Gross Margin
68%
Oper. Margin
-442%
Profit Margin
-442%
Payout
-
Shs Outstand
161.66M
Shs Float
159.8M
-
-
-
-
Target Price
65.7
52W Range
27.38-156.82
52W High
-74.15%
52W Low
+49.33%
RSI
54.54
Rel Volume
0.73
Avg Volume
6.2M
Volume
4.54M
Perf Week
4.73%
Perf Month
21.41%
Perf Quarter
-37.97%
Perf Half Y
-46.87%
-
-
-
-
Beta
0.788846
-
-
Volatility
1.38%, 2.33%
Prev Close
6.13%
Price
40.32
Change
5.3%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
4.216.357.712.0922.46
Net income per share
-1.93-1.47-1.38-5.36-4.74
Operating cash flow per share
-0.62-0.070.42-0.592.14
Free cash flow per share
-0.72-0.20.26-0.881.44
Cash per share
2.217.277.28.699.9
Book value per share
10.0815.3914.11175.49177.28
Tangible book value per share
-1.790.430.59-7.94-4.07
Share holders equity per share
10.0815.3914.11175.49177.28
Interest debt per share
4.066.696.616.5115.03
Market cap
2.01B4.09B7.53B23.88B6.37B
Enterprise value
2.18B4.08B7.46B24.58B6.76B
P/E ratio
-18.84-42.1-76.12-49.22-14.86
Price to sales ratio
8.629.7813.621.833.13
POCF ratio
-58.42-840.95251.96-446.2532.85
PFCF ratio
-50.36-308.06396.74-300.1748.99
P/B Ratio
3.64.037.421.50.4
PTB ratio
3.64.037.421.50.4
EV to sales
9.339.7613.4822.473.32
Enterprise value over EBITDA
-30.91-115.67-210.11-56.19-79.82
EV to operating cash flow
-63.2-839.03249.65-459.3334.84
EV to free cash flow
-54.47-307.36393.11-308.9751.97
Earnings yield
-0.05-0.02-0.01-0.02-0.07
Free cash flow yield
-0.020000.02
Debt to equity
0.370.410.430.090.08
Debt to assets
0.320.340.370.110.1
Net debt to EBITDA
-2.340.261.94-1.6-4.57
Current ratio
3.878.536.523.193.7
Interest coverage
-4.31-2.71-2.77-8.37-3.31
Income quality
0.320.05-0.30.11-0.45
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.350.280.30.460.22
Research and developement to revenue
0.150.130.120.150.15
Intangibles to total assets
0.80.640.610.940.93
Capex to operating cash flow
0.161.73-0.360.49-0.33
Capex to revenue
-0.02-0.02-0.02-0.02-0.03
Capex to depreciation
-0.29-0.24-0.24-0.33-0.29
Stock based compensation to revenue
0.130.10.120.430.15
Graham number
20.9122.5920.9145.48137.47
ROIC
-0.1-0.05-0.05-0.03-0.02
Return on tangible assets
-0.64-0.18-0.16-0.42-0.32
Graham Net
-2.22-0.07-0.4-10.27-6.96
Working capital
115.91M470.3M497.82M726.96M894.43M
Tangible asset value
-99.43M28.53M42.49M-718.32M-368.7M
Net current asset value
-109.25M16.98M-800K-811.87M-463.41M
Invested capital
0.370.410.440.090.08
Average receivables
98.19M106.43M113.11M169.28M169.12M
Average payables
24.96M26.9M27.55M46.03M46.64M
Average inventory
00056.5M64.79M
Days sales outstanding
42.3938.0537.5756.4830.34
Days payables outstanding
23.0122.0317.9642.9926.53
Days of inventory on hand
00052.7641.02
Receivables turnover
8.619.599.726.4612.03
Payables turnover
15.8716.5720.338.4913.76
Inventory turnover
0006.928.9
ROE
-0.19-0.1-0.1-0.03-0.03
Capex per share
-0.1-0.13-0.15-0.29-0.71

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
3.223.273.473.523.67
Net income per share
-0.86-0.53-0.07-41.58-19.22
Operating cash flow per share
0.330.480.52-0.20.57
Free cash flow per share
0.250.390.38-0.390.3
Cash per share
5.045.185.65.235.48
Book value per share
102.53100.28100.3256.9537.7
Tangible book value per share
-2.67-2.6-2.31-3.99-4
Share holders equity per share
102.53100.28100.3256.9537.7
Interest debt per share
8.148.078.129.919.8
Market cap
25.95B20.22B14.69B11.58B5.36B
Enterprise value
26.42B20.66B15.07B12.33B6.06B
P/E ratio
-48.48-59.93-334.23-0.43-0.43
Price to sales ratio
51.5838.7626.520.489.05
POCF ratio
496.97263.97176.5-364.7357.96
PFCF ratio
655.93328.8243.6-185.04112.52
P/B Ratio
1.621.260.921.270.88
PTB ratio
1.621.260.921.270.88
EV to sales
52.539.6127.221.8110.22
Enterprise value over EBITDA
-479.79-3.07K993.26-1.87-3.08K
EV to operating cash flow
505.91269.76181.15-388.3465.49
EV to free cash flow
667.72336.01250.02-197.01127.14
Earnings yield
-0.0100-0.58-0.58
Free cash flow yield
000-0.010.01
Debt to equity
0.080.080.080.170.26
Debt to assets
0.090.090.10.180.25
Net debt to EBITDA
-8.48-65.8825.48-0.11-354.39
Current ratio
43.833.73.943.38
Interest coverage
-3.86-3.21-2.2-1.22K-713.98
Income quality
-0.39-0.91-7.570-0.03
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.220.20.210.190.19
Research and developement to revenue
0.160.150.130.150.14
Intangibles to total assets
0.930.930.930.880.83
Capex to operating cash flow
-0.24-0.2-0.280.97-0.48
Capex to revenue
-0.03-0.03-0.04-0.05-0.08
Capex to depreciation
-0.23-0.27-0.4-0.49-0.71
Stock based compensation to revenue
0.160.140.110.110.09
Graham number
44.4834.5512.45230.82127.69
ROIC
000-0.62-0.4
Return on tangible assets
-0.11-0.07-0.01-5.1-2.26
Graham Net
-4.23-4.24-3.94-5.7-5.89
Working capital
828.61M855.21M894.43M901.36M885.79M
Tangible asset value
-416.81M-414.83M-368.7M-641.08M-645.72M
Net current asset value
-505.21M-507.68M-463.41M-741.68M-760.86M
Invested capital
0.080.080.080.170.26
Average receivables
196.89M196.21M191.65M214.35M209.89M
Average payables
44.74M41.03M47.33M47.41M70.89M
Average inventory
63.82M63.8M71.87M70.65M65.46M
Days sales outstanding
32.130.7227.4434.1231.21
Days payables outstanding
23.6318.4524.3122.8246.55
Days of inventory on hand
3230.3137.593429.72
Receivables turnover
2.82.933.282.642.88
Payables turnover
3.814.883.73.941.93
Inventory turnover
2.812.972.392.653.03
ROE
-0.01-0.010-0.73-0.51
Capex per share
-0.08-0.09-0.14-0.19-0.28

Something similar